Immunoactivating peptide P4 augments alveolar macrophage phagocytosis in two diverse human populations

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4566-4569

  Bangert, Mathieu ^a,d   Wright, Adam K ^a   Rylance, Jamie ^b   Kelly, Matthew J ^b   Wright, Angela D ^a   Carlone, George M ^c   Sampson, Jacquelyn S ^c   Rajam, Gowrisankar ^c   Ades, Edwin W ^c   Kadioglu, Aras ^d   Gordon, Stephen B ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOACTIVATING PEPTIDE P4; PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; HUMAN; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; OXIDATION; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOKINES; FEMALE; GENE EXPRESSION; GREAT BRITAIN; HEALTHY VOLUNTEERS; HUMANS; MACROPHAGES, ALVEOLAR; MALAWI; MALE; OLIGOPEPTIDES; OXIDATION-REDUCTION; PHAGOCYTOSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 84882441694     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00742-13     Document Type: Article

References (10)

1. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. 2006. Antibiotic therapy and 48-hour mortality for patients with pneumonia. Am. J. Med. 119:859-864.
2. Rajam G, Phillips DJ, White E, Anderton J, Hooper CW, Sampson JS, Carlone GM, Ades EW, Romero-Steiner S. 2008. A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization. Microb. Pathog. 44:186-196.
3. Rajam G, Skinner J, Melnick N, Martinez J, Carlone GM, Sampson JS, Ades EW. 2009. A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection. J. Infect. Dis. 199:1233-1238.
4. Bangert M, Bricio-Moreno L, Gore S, Rajam G, Ades EW, Gordon SB, Kadioglu A. 2012. P4-mediated antibody therapy in an acute model of invasive pneumococcal disease. J. Infect. Dis. 205:1399-1407.
5. Weeks JN, Boyd KL, Rajam G, Ades EW, McCullers JA. 2011. Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia. Antimicrob. Agents Chemother. 55:2276-2281.
6. Rajam G, Hammons GM, Carlone GM, Sampson JS, Ades EW. 2011. A novel innate immune-enhancement strategy combined with IVIG rescues mice from fatal Staphylococcus aureus septicemia. Int. J. Microbiol. 2011: 725483.
7. Rajam G, Bangert M, Hammons GM, Melnick N, Carlone GM, Sampson JS, Ades EW. 2010. P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis. Clin. Vaccine Immunol. 17:1823-1824.
8. Melnick N, Rajam G, Carlone GM, Sampson JS, Ades EW. 2009. Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model. Clin. Vaccine Immunol. 16:806-810.
9. Wang H, Joseph JA. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27: 612-616.
10. Fullerton DG, Suseno A, Semple S, Kalambo F, Malamba R, White S, Jack S, Calverley PM, Gordon SB. 2011. Wood smoke exposure, poverty and impaired lung function in Malawian adults. Int. J. Tuberc. Lung Dis. 15:391-398.